# Dyne Therapeutics, Inc.: Form 8-K, filed Dec 9, 2020

- Company: [Dyne Therapeutics, Inc.](/companies/dyn.md) (CIK 1818794)
- Form: 8-K
- Filed: 2020-12-09
- Accepted by EDGAR: Dec 9, 2020, 17:28 ET
- Period: 2020-12-04
- Accession: 0001193125-20-313953
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1818794/000119312520313953/d27427d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818794/000119312520313953/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818794/000119312520313953/d27427d8k.htm

Filed Dec 9, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-313953. Last ingested by Listed: Nov 5, 2026, 12:06 ET. No prices; not investment advice.